Singapore markets closed

Kiromic BioPharma, Inc. (KRBP)

OTC Markets OTCPK - OTC Markets OTCPK Delayed price. Currency in USD
Add to watchlist
3.2000-0.0200 (-0.62%)
At close: 01:37PM EDT
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Cash flows from operating activities
Net income
-21,797
-20,949
-34,731
-25,589
-19,200
-
Depreciation & amortisation
2,222
2,221
1,673
469.8
200
-
Stock-based compensation
177.3
141.3
1,237
3,763
13,246
-
Change in working capital
-3,917
-3,213
4,370
710.3
-394.5
-
Accounts receivable
-
0
16.2
9.8
0
-
Inventory
-
-
-
-
0
-5.9
Accounts payable
-6,026
-5,035
3,791
1,411
-7.7
-
Other working capital
-23,024
-21,432
-28,626
-22,216
-7,584
-
Other non-cash items
518.8
574.8
3,718
-
0.2
20.5
Net cash provided by operating activities
-22,796
-21,225
-23,746
-20,321
-6,127
-
Cash flows from investing activities
Investments in property, plant and equipment
-
-206.6
-4,880
-1,895
-1,458
-
Net cash used for investing activities
-227.6
-206.6
-4,865
-1,811
-1,458
-
Cash flows from financing activities
Debt repayment
-602.2
-557.2
-508
-573.7
-188.1
-
Common stock issued
-
659.1
0
40,000
15,000
-
Other financing activities
-
-111.2
-200
-2,882
-2,667
-
Net cash used provided by (used for) financing activities
24,646
23,991
3,903
37,336
15,806
-
Net change in cash
1,622
2,559
-24,709
15,203
8,221
-
Cash at beginning of period
2,054
645.2
25,354
10,151
1,929
-
Cash at end of period
3,676
3,204
645.2
25,354
10,151
-
Free cash flow
Operating cash flow
-22,796
-21,225
-23,746
-20,321
-6,127
-
Capital expenditure
-
-206.6
-4,880
-1,895
-1,458
-
Free cash flow
-23,024
-21,432
-28,626
-22,216
-7,584
-